The adaptor protein Nck consists of three Src homology 3 (SH3) domains followed by one SH2 domain. Like the Grb2 adaptor protein, which is known to couple receptor tyrosine kinases to the activation of the small GTPase Ras, Nck is presumed to bind to tyrosine-phosphorylated proteins using its SH2 domain and to downstream effector proteins using its SH3 domain. Little is known, however, about the specific biological function of Nck. The Pak family of serine/threonine kinases are known to be activated by binding to the GTP-bound form of Cdc42 or Rac1, which are small GTPases of the Rho family that are involved in regulating the organization of the actin cytoskeleton.
Introduction
The controlled formation of protein complexes is a central theme in eukaryotic signal transduction. Signal-induced changes in protein-protein associations serve to relocalize proteins within the cell and to modulate their activities. Src homology 2 and 3 (SH2 and SH3) domains, which are small, modular domains found in a wide variety of proteins implicated in signaling, frequently mediate protein-protein interactions in signal transduction (reviewed in [1, 2] ). SH2 domains bind with high affinity to tyrosine-phosphorylated proteins [3, 4] , whereas SH3 domains bind to proline-rich peptides. Individual SH2 and SH3 domains also have individual binding specificities -different domains bind with highest affinity to different spectra of ligands -although it is clear that, to some extent, the specificities of different SH2 or SH3 domains overlap [5] [6] [7] [8] .
SH2/SH3 adaptor proteins consist almost entirely of SH2 and SH3 domains, and lack intrinsic enzymatic activity, suggesting that they serve to couple upstream tyrosinephosphorylated signaling molecules, bound by the SH2 domains, to downstream SH3-binding effectors [1, 2] . The prototype adaptor protein is Grb2 [9] ; genetic studies have implicated Grb2 in signaling pathways involved in vulva development in Caenorhabditis elegans and eye development in Drosophila. In each system, the adaptor protein was shown to function downstream of a receptor tyrosine kinase and upstream of the small GTP-binding protein Ras [10] [11] [12] . Biochemical studies have shown that Grb2 binds via its two SH3 domains to a proline-rich region of Sos, a guanine-nucleotide exchange factor for Ras. Therefore, activation of a tyrosine kinase generates binding sites for the Grb2 SH2 domain, and Grb2 then uses its SH3 domains to bring Sos to the plasma membrane, where Sos can activate its substrate, Ras, which is also localized at the membrane (reviewed in [13] ).
The SH2/SH3 adaptor protein Nck consists of three SH3 domains followed by one SH2 domain [14] . Nck is expressed in a wide range of tissues and cell lines, and is phosphorylated on serine, threonine and tyrosine residues following stimulation of cells with growth factors [15] [16] [17] . Overexpression of Nck can lead to transformation of fibroblasts [15, 18] , and can also inhibit the neural differentiation of PC12 cells in a way that is independent of the mitogen activated protein kinase (MAP kinase) pathway [19] . We have shown previously that dominant-negative Nck mutants could not block the Ras-dependent activation of the MAP kinase Erk1 (extracellular receptoractivated kinase 1) in experiments in which similar mutants of Crk, another adaptor protein, and of Grb2 were able to block Erk1 activation, suggesting that Nck might have a different function from Grb2 and Crk [20] . In Drosophila, an Nck homolog was shown to be involved in axon guidance and targeting in photoreceptor cells [21] , but the molecular mechanisms involved are still not clear.
It has been shown that the SH2 domain of Nck binds the receptor for platelet-derived growth factor (PDGF), the insulin receptor substrate-1 (IRS-1), Src and focal adhesion kinase (FAK) [18, [22] [23] [24] . The SH3 domains of Nck have been shown to associate with a number of proteins including Sos [25] , c-Cbl [26] , a 65 kDa serine/threonine kinase termed NAK [27] , the Wiskott-Aldrich syndrome protein WASP [28] and PRK2, a serine/threonine kinase closely related to the putative Rho effector protein kinase N (PKN) [29] . Recently, two groups have also suggested that Nck links receptor tyrosine kinases to Pak1, a member of the Pak family of serine/threonine kinases [30, 31] . However, a role for any of these proteins in the biological activity of Nck has yet to be demonstrated.
Here, we present evidence for a biologically relevant association between Nck and Pak1. The family of Pak serine/threonine kinases can be directly activated by the Rho-family GTPases Cdc42 and Rac1 [32] [33] [34] , which regulate the organization of the actin cytoskeleton [35] . We show that Pak and Nck are associated in vivo, and that this association can be abolished by a single point mutation in the second SH3 domain of Nck. Membrane localization of either the second SH3 domain of Nck, or of Pak1 itself, led to the stimulation of Pak kinase activity and to activation of downstream MAP kinases, including Erk1. The activation of Erk1 by membrane-localized Nck could be stimulated by wild-type Pak1 and blocked by kinase-inactive Pak1. These data strongly suggest that the subcellular localization of Pak has important consequences in terms of its own activity and its ability to activate downstream signaling pathways, and point to Nck as a likely mediator of Pak relocalization in vivo.
Results and discussion
In order to identify potential downstream effectors of Nck, the individual SH3 domains of Nck were fused to glutathione S-transferase (GST) and used to probe cytoplasmic extracts made from Xenopus embryos at the gastrula stage. These extracts were initially chosen because they are a rich source of concentrated cytoplasm, and because Nck mRNA is highly expressed specifically during early Xenopus development (M. Tanaka, W.L., R.G. and B.J.M., unpublished observations). A combination of solution binding and filter-binding experiments consistently identified proteins of 68 kDa and 55 kDa that bound to the second and third SH3 domains of Nck. In situ phosphorylation assays demonstrated that a 68 kDa protein specifically bound by the second SH3 domain of Nck had kinase activity (data not shown), consistent with data of Chou et al. [27] , who had previously shown that a 68 kDa protein kinase associated with Nck in rat cell lysates.
Pak kinases are ~65-68 kDa and contain several potential SH3-binding motifs in their amino termini [36] , suggesting that the Nck-associated kinase might be a member of this family. To test whether Nck could bind Pak, proteins from frog cell extracts that bound to the SH3 domains of Nck were assayed for kinase activity in the presence of GTPgS-loaded Rho-family GTPases produced in bacteria [32, 33] . GTPgS-loaded Cdc42 and Rac1, but not RhoA, dramatically stimulated the activity of the kinase bound to the SH3 domains of Nck (Fig. 1a) . This activity was specifically associated with the second SH3 domain of Nck (Fig. 1b) . These results demonstrate that a protein in Xenopus extracts that binds to the second SH3 domain of Nck has the properties of a Pak family kinase. This is In vitro kinase activity from Xenopus lysates bound by first, second, and third SH3 domains of Nck, assayed in the presence of GTPgSloaded Cdc42. The arrow indicates a 65-68 kDa doublet. 
consistent with recent data showing that Nck can bind to overexpressed Pak3 [37] and Pak1 [30, 31] . We could also demonstrate association of endogenous Nck and Pak in murine NIH 3T3 fibroblasts by co-immunoprecipitation (Fig. 3a) . Although the proportion of total Nck and Pak that could be coprecipitated was low, it was clearly detectable. The association of endogenous Pak and Nck was further confirmed by detection of GTP-Cdc42-stimulated kinase activity in anti-Nck immunoprecipitates (Fig.  3b) . This demonstrates that, in at least some cell types, endogenous Nck and Pak exist in a preformed complex.
Because the biological role of Nck is currently unknown, it is impossible to assess the significance of the Nck-Pak association directly. We therefore designed experiments based on general models of the function of SH2/SH3 adaptor proteins, to test its significance indirectly. By analogy to Grb2, we surmised that the SH2 domain of Nck would bind to tyrosine-phosphorylated sites and induce relocalization of Nck-associated proteins in response to changes in tyrosine phosphorylation. The Nck SH2 domain has been shown to bind membrane-associated proteins, such as the growth factor receptors IRS-1 and FAK [18, [22] [23] [24] . To mimic binding of full-length Nck to such targets, we therefore fused the second, Pak-binding SH3 domain of Nck (SH3-2) to either the Src myristoylation signal [38, 39] , or the focal adhesion target (FAT) domain of FAK [40, 41] . These fusion proteins are expected to be constitutively targeted to membranes and focal adhesions, respectively, whereas the unfused SH3 is expected to be cytosolic.
We first examined the biochemical consequences of relocalization of Nck and Pak. We considered that relocalization of Pak could affect its activity in at least two ways: first, relocalization could lead to activation of Pak by altering its accessibility to GTP-bound Cdc42, Rac or other activators; second, it could affect its accessibility to potential downstream substrates. Pak1 was cotransfected into 293T cells with the wild-type Nck SH3-2 domain, myristoylated Nck SH3-2 (Src-SH3-2), or myristoylated SH3-2 containing a point mutation that eliminates ligand binding (Src-SH3-2 K143; see In order to confirm that Pak1 activation was not due to indirect effects of expression of myristoylated SH3-2, we used a Pak1 mutant (P13A) with a single amino-acid change in the first proline-rich region which results in impaired binding to the SH3 domain of Nck [30] . Unlike wild-type Pak, the P13A mutant was not significantly activated in cells expressing the myristoylated SH3-2 domain (Fig. 4, lane 7) . Nevertheless, the P13A mutant had the same in vitro kinase activity as wild-type Pak1 in the absence or presence of GTP-loaded Cdc42 when isolated from cells not expressing myristoylated SH3-2 (Fig. 4 , lanes 1 and 5 of bottom panels). This strongly suggests that activation of Pak by myristoylated SH3-2 involves direct association of Pak and Nck, and is not an indirect effect of expression of the myristoylated SH3. To confirm that membrane localization of Pak is sufficient for its activation, we made a Pak construct in which the Src myristoylation signal is directly fused to the amino terminus of Pak1. Myristoylated Pak1 from transfected 293T cells had approximately three-fold higher in vitro kinase activity in the absence of GTP-loaded Cdc42 than did the wild-type protein (Fig. 5) . As has been seen with other Src myristoylation signal fusion proteins, the Src-SH3-2 and Src-Pak fusion proteins were found entirely in the P100 membrane fraction of cells after hypotonic lysis (data not shown). In contrast to the results with myristoylated SH3-2, expression of the FAT-SH3-2 fusion did not result in activation of Pak (data not shown).
We also consistently observed that 293T cells transfected with the myristoylated SH3-2 domain became round and nonadherent, whereas cells transfected with the soluble SH3 construct were indistinguishable from vector-transfected controls. In agreement with the assumption that these morphological changes were caused by targeting of Pak to the membrane, expression of Pak1 fused to the Src myristoylation signal also induced rounding of 293T cells, whereas overexpression of the unmodified Pak1 did not (data not shown). The morphological changes suggest that constitutively targeting Pak to the membrane has biological effects.
In order to assess more quantitatively the downstream effects of Nck-mediated Pak relocalization, we examined the activation of downstream signaling kinases. MAP kinase cascades encompass three distinct but interconnected pathways that result in the activation of three kinase families: the Erk, c-Jun N-terminal kinase/stressactivated kinases (JNK/SAPK) and the p38 kinases [42] .
To test whether these specific signal transduction pathways are activated upon Pak1 relocalization, GST-Erk1, GST-SAPKb and GST-p38 were each introduced into 293T cells as cotransfections with the various Nck SH3-2 and Pak constructs. GST fusion proteins were subsequently isolated from transfected cell lysates and subjected to in vitro kinase assay. As expected, myristoylated Nck SH3-2 led to activation of p38, whereas the unmyristoylated domain did not (Fig. 6a) , consistent with data from other groups showing that Pak1 is upstream of p38 [43, 44] . JNK/SAPK was activated to a lesser extent (data not shown). More surprisingly, expression of myristoylated Nck SH3-2 resulted in approximately five-fold activation of GST-Erk (Fig. 6b, lane 4) , whereas the soluble or FAT-fused SH3 domain did not (lanes 2 and 3), consistent with the inability of these constructs to activate Pak. Because the activation of Erk was unexpected, we tested whether the activation of Erk upon expression of myristoylated Nck SH3 was consistent with its being a consequence of relocalization of Pak to the membrane (Fig. 6b,c) . Overexpression of wild-type Pak1 alone was sufficient to activate Erk moderately in this system (lane 5), but expression of the myristoylated Pak1 resulted in two-fold stronger activation than wild-type Pak (lane 6). The activation of Erk induced by overexpression of wildtype Pak was augmented by the presence of the myristoylated Nck SH3, which would direct Pak to the membrane (lane 8), and inhibited to basal levels by the unmodified SH3 domain, which would sequester Pak in the cytosol (lane 7). Finally, the activation of Erk by myristoylated Nck SH3 could be blocked by overexpression of kinase-inactive Pak1 (Fig. 6d) . Taken together, these results strongly suggest that the recruitment of Pak1 to the membrane is sufficient for its own activation and for activation of the Erk signaling pathway, and that Pak1 activity is necessary for the activation of Erk by membrane-localized Nck. We found that relocalization of Pak to the membrane led to activation of the Erk pathway, although our experiments do not address to what extent Erk activation is a direct effect. The result was somewhat surprising, as Pak has previously been implicated in activation of the stressactivated p38 and JNK/SAPK pathways [43] [44] [45] [46] [47] . We suspect that the specific downstream pathways activated by Pak might depend on its subcellular localization, because different substrates might be available to the activated Pak in different compartments.
Experiments suggesting that JNK/SAPK and p38 are more responsive than Erk to Pak activity have generally involved overexpression of constitutively-active or dominant-negative Pak (or Rho-family GTPases) [43] [44] [45] [46] [47] [48] [49] .
In interpreting these experiments, we must consider that the subcellular localization of constitutively-activated Pak is likely to be different from that of Pak activated by normal signals, when its localization might be very restricted. Dominant-negative experiments must also be interpreted with caution until the specific mechanism of inhibition -that is, what proteins are being sequestered -is known. In our experiments, Pak is specifically activated by membrane targeting in the absence of other stimulatory or inhibitory signals, so the downstream effects are likely to be due solely to Pak activity.
In addition to our work, other evidence for the involvement of Rho-family GTPases in the Erk pathway is beginning to accumulate. For example, a dominant-negative version of Rac1 was found to block v-Abl-induced transcriptional activation via the tetra-phorbol acetate (TPA) response element (TRE) and serum response element (SRE) enhancers, and also compromised v-Abl-induced activation of Erk2 [50] . Work from the Cobb group [44] also showed that expression of dominant-negative Rac1 or the amino terminus of Pak1 could inhibit the Ras-mediated activation of Erk2, and that constitutively-activated Cdc42, Rac and Rho synergized with activated Raf to increase Erk2 activity.
It is also becoming clear that the signaling pathways activated by Rho-family GTPases and Pak can vary in different cells and in different experimental systems. For example, studies with Cdc42 and Rac1 mutants showed a strong correlation between Pak activation and JNK activation by Cdc42 and Rac1 [51] , whereas another group recently showed that MLK3, and not Pak1, mediated JNK activation by activated Cdc42 [52] . In addition, although it is generally well accepted that Cdc42 and Rac1, but not Rho A, activate JNK kinases [48, 49] , Gutkind and colleagues [53] recently showed that, while Cdc42 and Rac1 activated the JNK pathway in Cos-7 cells, as expected, in 293T cells, Cdc42 and RhoA, but not Rac1, activated JNK. Irrespective of whether Erk is a major effector of Nck and Pak in all cases, our experiments demonstrate that Nck, and perhaps other SH3-containing Pak-binding proteins, is likely to couple tyrosine kinase-mediated signaling pathways to those regulated by Rho-family GTPases.
Conclusions
Pak kinases are of considerable interest because they have been shown to be directly activated by Rho family GTPases, which have in turn been implicated in regulating the organization of the actin cytoskeleton. The Rhofamily GTPases and Pak kinases have also been implicated in the activation of stress-activated MAP kinase signaling cascades. It is still unclear, however, what role Pak plays in normal cellular signals. We have found that membrane localization of Pak1, either by direct fusion to a myristoylation signal or by relocalization mediated by binding to an SH3 domain of the Nck adaptor protein, is sufficient to stimulate its kinase activity and activate downstream MAP kinase cascades. Pak relocalization by means of association with Nck provides a straightforward mechanism for coupling the activation of Pak to extracellular signals involving tyrosine phosphorylation (Fig. 7) . The observation that membrane localization is sufficient to activate Pak in the absence of other signals or activators implies that subcellular localization, and not the availability of GTP-loaded Rhofamily GTPases, can limit the activation state of Pak in growing cells.
Materials and methods

SH3 binding and kinase assays in Xenopus lysates
Individual SH3 domains of Nck were generated by polymerase chain reaction (PCR) from human Nck cDNA, cleaved with BamHI and NotI, and inserted into pGEX-2N to make bacterial GST fusion constructs. GST-SH3-1 contains Nck residues 1-63, SH3-2 residues 106-166 and SH3-3 residues 189-257. Fusion proteins were expressed and purified from bacteria as described [54] .
Early gastrula-stage Xenopus embryos were collected and washed three times with PBS followed by lysis in TXB buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 % glycerol, 1 mM sodium orthovanadate, 1 % Triton X-100 plus protease inhibitors). Yolk proteins and insoluble material were removed by centrifugation. Embryo lysate containing 2 mg protein in a volume of 200 ml was added to 10 mg of GST fusion proteins bound to 10 ml of glutathione-sepharose (Pharmacia) and rotated at 4°C for 30 min followed by three washes with TXB. Washed beads were subjected to in vitro kinase assay in 50 mM Hepes pH 7.5, 10 mM MgCl 2 , 100 mM ATP and 10 mCi g-[ 32 P ]ATP for 10 min at 30°C, in the presence of 2 mg of GTPgS-or GDP-loaded Cdc42, Rac1 and RhoA prepared as described [32] . Reaction products were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and gels were fixed and exposed for autoradiography.
Constructs for mammalian cell expression
Amino-terminally Myc-tagged wild-type, P13A, and K299R human Pak1 clones were kindly provided by J. Chernoff. The K299R mutation is in the ATP-binding site and inactivates the kinase [43] . The construction of the W143K Nck mutant (termed K143 here) has been described [20] . Oligonucleotides encoding the influenza virus hemagglutinin (HA) epitope tag [55] were synthesized and subcloned into the Asp718 and NotI site of pEBB [20] to make pEBB-HA. For the unmyristoylated clones, SH3-2 or Pak1 were subcloned by PCR into the BamHI and Asp718 sites of pEBB-HA. SH3-2 consists of residues 100-169 of the human Nck protein and HA-Pak1 contains the full-length human gene. For the myristoylated clones, the 14 amino-acid v-Src myristoylation signal was first synthesized by PCR with a BglII site at the 5′ end and BamHI and Asp718 sites at the 3′ end. The PCR product was digested with BglII and Asp718 and then cloned into the BamHI and Asp718 sites of pEBB-HA to make pEBB-SrcHA. SH3-2 and Pak1 were then cloned into pEBBSrcHA. The FAT site consists of the carboxy-terminal 200 amino acids of chicken FAK. It was subcloned by PCR into the Asp718 and NotI sites of HA-tagged pEBB-SH3-2 replacing the HA tag. 
Cytoplasm
Mammalian cell transfection, immunoprecipitation and in vitro kinase assay
Transfection of 293T cells followed the calcium phosphate method as described [20] . The cells were lysed 48 h later in 1 ml TXB per 10 cm dish. Monoclonal or affinity-purified polyclonal antibody (1 mg) or crude rabbit serum (5 ml) was incubated with 200 ml cell lysate for 2 h at 4°C and precipitated with protein G-agarose (Pierce). Immunoprecipitates were washed extensively before immunoblotting or in vitro kinase assay. Immunoblotting was as described [56] . In vitro kinase assays of immunoprecipitates were performed in 50 mM Hepes pH 7.5, 10 mM MgCl 2 , 100 mM ATP and 10 mCi [g-32 P ]ATP for 10 min at 30°C with 0.1 mg ml -1 MBP as substrate. GTPgS-Cdc42 (2 mg) was added to each 20 ml reaction where noted.
The antibodies against the amino-terminal 20 amino acids of Pak1 (used for immunoblotting) and the Myc epitope tag were from Santa Cruz. The antibody against the HA epitope tag was from Berkeley Antibody Co. The anti-Nck antibody for immunoblotting was from Transduction Laboratories. The anti-Nck and Pak1 antibodies for immunoprecipitation were raised in rabbits immunized with GST fused to full-length human Nck or GST fused to the amino-terminal 266 residues of human Pak1, and the anti-Nck antibodies were affinity-purified using immobilized immunogen.
Activation of MAP kinases
pEBG-Erk1 or pEBG-p38 (4 mg each) was cotransfected with 4 mg other plasmids. Positive control cells were treated with 100 ng ml -1 EGF for 30 min before harvesting; 48 h post-transfection, cells were lysed in 1 ml ice-cold kinase lysis buffer (25 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 % Triton X-100, 10 mM sodium pyrophosphate, 10 mM b-glycerophosphate, 1 mM sodium orthovanadate, 10 % glycerol, 1 mM PMSF and 20 mg ml -1 aprotinin). GST fusion proteins were purified from cell lysates by binding to glutathione-agarose beads and eluted with 50 mM Hepes pH 7.5, 20 mM glutathione, and 10 % glycerol. Purified kinases were normalized by Coomassie blue staining and in vitro kinase assays were performed with equal amounts of kinase. Reaction conditions were as above with 0.1 mg ml -1 MBP included as exogenous substrate.
For the inhibition of Erk1 activation by kinase-inactive Pak1, 0.1 mg Src-SH3 plasmid was cotransfected with 4 mg pEBG-Erk with or without 10 mg Pak1 mutant plasmid; 24 h after transfection, the cells were lysed and activity assayed as above.
